Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Methods to Evaluate Novel Hepatitis C Virus VaccinesGustaf Ahlén, Lars FrelinGenome Medicine|April 8, 2009
A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humansLars Frelin, Matti SällbergMethods in Molecular Biology (Clifton, N.J.)|October 30, 2012
Methods for monitoring gene gun-induced HBV- and HCV-specific immune responses in mouse modelsGustaf Ahlén, Matti Sällberg, Lars FrelinExpert Opinion on Biological Therapy|June 17, 2009
DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving targetMatti Sällberg, Lars Frelin, Ola WeilandVaccine|April 26, 2016
A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccinesSepideh Levander, Matti Sällberg, Gustaf Ahlén, et al.Medical Microbiology and Immunology|December 24, 2014
Electroporation for therapeutic DNA vaccination in patientsMatti Sällberg, Lars Frelin, Gustaf Ahlén, et al.Expert Review of Vaccines|December 15, 2015
Prospects and progress of DNA vaccines for treating hepatitis BMargaret Chen, Neetu Jagya, Ruchi Bansal, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2014
Functional aspects of intrahepatic hepatitis B virus-specific T cells induced by therapeutic DNA vaccinationAnette Brass, Lars Frelin, David R Milich, et al.Molecular Therapy. Methods & Clinical Development|April 13, 2016
A targeted controlled force injection of genetic material in vivoGustaf Ahlén, Lars Frelin, Fredrik Holmström, et al.Scientific Reports|May 5, 2016
Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responsesFredrik Holmström, Margaret Chen, Anangi Balasiddaiah, et al.Pageof 5